Is 4-AcO-DMT legal in Saudi Arabia?

Legal status

Not established, and the reason is a specific gap in the coverage wording rather than an absence of neighbours. The schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version issued on 4 September 2026, were searched from Schedule I to Schedule IV for 4-AcO-DMT and no matching entry was verified. The search record reads «سجل البحث الخاص بـ 4-aco-dmt: فُحصت الجداول من الأول إلى الرابع ولم يُتحقق من قيد مطابق.», the item specific search record for 4-AcO-DMT, the schedules from the first to the fourth were examined and no matching entry was verified. What was searched: “4-AcO-DMT”, “O-acetylpsilocin”, “psilacetin”, «4 أسيتوكسي دي ام تي». Psilocin and DMT are both named in the schedules, and that is exactly why the row cannot be resolved by proximity: 4-AcO-DMT is the acetate ester of psilocin, and the Schedule II Category A wording that was read supplies stereoisomer coverage rather than ester coverage. An ester is not a stereoisomer, and reading one clause as though it were the other is how a wrong answer gets written confidently. Absence of a verified entry is not a finding that the substance is lawful, and the schedules are kept current under M/39 Articles 70 to 71.

Consequences if caught

Capital exposure: none. That records what this pass established for 4-AcO-DMT and not how a Saudi court would treat a sample. Article 37(I) is the capital route in M/39, it carries no quantity threshold of any kind, and its death sentence is reducible by the court under Article 37(II) to a prison term of not less than fifteen years with the stated lashes and fine. None of that is assigned to this row, because the exact Schedule I or Schedule II entry, or a qualifying Schedule IV reach, was not verified. The qualification that matters here is chemical rather than legal. 4-AcO-DMT is metabolised to psilocin, psilocin is named in the schedules and Schedule IV separately names the fungi that produce it, so a laboratory result reporting psilocin in a seized sample would put the Article 37 route back on the table through that constituent.

If prescribed or medical

The Saudi traveller rule is a permit rule rather than a prescription rule. A controlled medicine may be brought in only under a clearance obtained from the SFDA before travel through its Controlled Drugs System, and that advance electronic clearance is required rather than optional. A foreign prescription is not a Saudi clearance. For 4-AcO-DMT the schedule placement that would normally be attached to that rule was not established, so it cannot be attached here, and which permit category a 4-AcO-DMT preparation would fall into is deferred rather than answered. No Saudi dispensing route and no medicinal product containing 4-AcO-DMT was recorded.

Documentation

There is nothing to carry for this substance, because no lawful import route was established for it. For any controlled medicine, apply through the SFDA Controlled Drugs System before travelling, carry the clearance and not the prescription alone, bring the medicine in its original dispensing packaging with the prescription and a medical report translated into Arabic and dated less than six months before travel, keep to a one month supply or the length of the stay, and declare it at customs; advance electronic clearance has been required since 1 November 2025. The permit mechanics stated here are the SFDA traveller rules recorded on the current live cell and were not re-derived from the instrument in this pass. The failed schedule search for 4-AcO-DMT was run against the 4 September 2026 schedules on 17 September 2026 and is recorded above so that a later reader can repeat it rather than restate it.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Saudi Arabia’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.